Clozapine rechallenge after mild neutropenia: risk stratification and monitoring?
29M with treatment-resistant schizophrenia who had dramatic improvement on clozapine (BPRS dropped from 68 to 32 over 6 months). He was discontinued 3 months ago when ANC dropped to 1400/microL (mild neutropenia per clozapine REMS).
He has since deteriorated significantly on olanzapine (BPRS back to 62, one psychiatric hospitalization). No alternative antipsychotic has provided adequate response.
Questions:
- What is the evidence for clozapine rechallenge after mild neutropenia (ANC > 1000)?
- Do you use lithium augmentation to support neutrophil counts during rechallenge?
- What ANC monitoring frequency do you use during rechallenge?
- At what ANC threshold do you permanently discontinue?
1 Answer
This is a scenario where the risk of withholding clozapine (psychosis relapse, hospitalization, potential self-harm) outweighs the risk of rechallenge in mild neutropenia. My approach:
1. Evidence for rechallenge: Several case series and a systematic review by Manu et al. (2018) showed that clozapine rechallenge after mild neutropenia (ANC > 1000) is successful (no recurrence of neutropenia) in approximately 60 to 70% of cases. The risk of agranulocytosis on rechallenge is approximately 2 to 3%, concentrated in the first 18 weeks.
2. Lithium augmentation: Yes, I routinely add lithium carbonate 300 to 600 mg/day (target level 0.4 to 0.8 mEq/L) starting 2 weeks before clozapine rechallenge. Lithium stimulates granulopoiesis and can increase ANC by 1000 to 2000/microL. This provides a "buffer" during rechallenge. The Brunoni et al. (2015) meta-analysis supports lithium's granulopoietic effect.
3. Monitoring frequency: Weekly ANC for the first 26 weeks (more stringent than the standard REMS protocol for initial treatment). After 26 weeks without neutropenia, biweekly for 6 months, then monthly thereafter.
4. Permanent discontinuation threshold: ANC < 500/microL (severe neutropenia/agranulocytosis) is an absolute contraindication to further rechallenge. For ANC 500 to 1000, I discontinue and do not rechallenge. For ANC 1000 to 1500, I reduce dose first and add G-CSF (filgrastim) before considering discontinuation.